Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Operating Expenses: 2019-2024

Historic Operating Expenses for Cellebrite DI (CLBT) over the last 6 years, with Dec 2024 value amounting to $281,704.

  • Cellebrite DI's Operating Expenses fell 99.88% to $86,725 in Q3 2025 from the same period last year, while for Sep 2025 it was $321,396, marking a year-over-year decrease of 99.88%. This contributed to the annual value of $281,704 for FY2024, which is 99.88% down from last year.
  • Per Cellebrite DI's latest filing, its Operating Expenses stood at $281,704 for FY2024, which was down 99.88% from $238.6 million recorded in FY2023.
  • Over the past 5 years, Cellebrite DI's Operating Expenses peaked at $238.6 million during FY2023, and registered a low of $281,704 during FY2024.
  • For the 3-year period, Cellebrite DI's Operating Expenses averaged around $152.6 million, with its median value being $218.9 million (2022).
  • In the last 5 years, Cellebrite DI's Operating Expenses rose by 28.45% in 2021 and then slumped by 99.88% in 2024.
  • Over the past 5 years, Cellebrite DI's Operating Expenses (Yearly) stood at $147.8 million in 2020, then rose by 28.45% to $189.9 million in 2021, then rose by 15.27% to $218.9 million in 2022, then increased by 9.04% to $238.6 million in 2023, then crashed by 99.88% to $281,704 in 2024.